CG Oncology (CGON) Gross Profit (2024 - 2026)

CG Oncology's (CGON) quarterly Gross Profit came in at -$1.9 million in Q1 2026, down 3713.46% YoY from $52000.0 in Q1 2025, and down 151.2% on a QoQ basis from -$748000.0 in Q4 2025.

CG Oncology (CGON) Gross Profit (2024 - 2026) Analysis & Trends

CG Oncology (CGON) has 3 years of Gross Profit data on file, last reported at -$1.9 million in Q1 2026.

  • Quarterly Gross Profit fell 3713.46% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (changed N/A YoY) and the FY2025 annual result came in at -$607000.0, down 153.29% from the prior year.
  • Gross Profit eased to -$1.9 million in Q1 2026, from -$748000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $456000.0 in Q4 2024 to a low of -$1.9 million in Q1 2026.
  • A 3-year average of -$331166.7 and a median of $47500.0 in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2025 — Gross Profit jumped 106.98% — and 2026, when it sank 3713.46%.
  • Tracing CGON's Gross Profit over 3 years: stood at $456000.0 in 2024, then slumped by 264.04% to -$748000.0 in 2025, then sank by 151.2% to -$1.9 million in 2026.
  • The last three Gross Profit figures came in at -$1.9 million (Q1 2026), -$748000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 CG Oncology 6.63 Bn 6.63 Bn -2.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.77 Mn
Jun 30, 2026 -2.77 Mn
Mar 31, 2026 -1.88 Mn
Mar 31, 2026 -1.88 Mn
Dec 31, 2025 -748,000.00
Dec 31, 2025 -748,000.00
Sep 30, 2025 89,000.00
Sep 30, 2025 89,000.00
Mar 31, 2025 52,000.00
Mar 31, 2025 52,000.00
Dec 31, 2024 456,000.00
Dec 31, 2024 456,000.00
Sep 30, 2024 43,000.00
Sep 30, 2024 43,000.00